Log in

Relevant bibliographies by topics / Idiopathic macular telangiectasia type 2 / Journal articles

To see the other types of publications on this topic, follow the link: Idiopathic macular telangiectasia type 2.

Journal articles on the topic 'Idiopathic macular telangiectasia type 2'

Author: Grafiati

Published: 4 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Idiopathic macular telangiectasia type 2.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Shukla, Dhananjay, Shashank R. Gupta, Nithya Neelakantan, et al. "TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA." Retina 32, no. 2 (2012): 265–74. http://dx.doi.org/10.1097/iae.0b013e31822091b0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Mozo Cuadrado, M., L. Tabuenca Del Barrio, E. Compains Silva, and D. Aliseda Pérez de Madrid. "Type 2 idiopathic macular telangiectasia (MacTel2)." Journal Français d'Ophtalmologie 43, no. 3 (2020): e103-e105. http://dx.doi.org/10.1016/j.jfo.2019.07.033.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Wu, Lihteh, Teodoro Evans, and J. Fernando Arevalo. "Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, Mac Tel 2)." Survey of Ophthalmology 58, no. 6 (2013): 536–59. http://dx.doi.org/10.1016/j.survophthal.2012.11.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Mirescu, Andrada Elena, Florian Balta, Ramona Barac, et al. "High-Resolution Imaging in Macular Telangiectasia Type 2: Case Series and Literature Review." Diagnostics 14, no. 13 (2024): 1351. http://dx.doi.org/10.3390/diagnostics14131351.

Full text

Abstract:

Background: Macular telangiectasia (MacTel), also known as idiopathic juxtafoveolar telangiectasis (IJFTs), involves telangiectatic changes in the macular capillary network. The most common variant, MacTel type 2, has distinct clinical features and management strategies. Methods: This study offers a comprehensive review of MacTel and focuses on a series of three patients diagnosed with MacTel type 2 in our clinic. A meticulous ophthalmological evaluation, augmented by high-resolution imaging techniques like optical coherence tomography (OCT), OCT angiography (OCT-A), fundus autofluorescence (F

APA, Harvard, Vancouver, ISO, and other styles

5

Khodabande, Alireza, Ramak Roohipoor, Javad Zamani, et al. "Management of Idiopathic Macular Telangiectasia Type 2." Ophthalmology and Therapy 8, no. 2 (2019): 155–75. http://dx.doi.org/10.1007/s40123-019-0170-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Chris, Putnam. "Idiopathic Macular Telangiectasia Type 2 and Its Relationship with Macular Pigment Optical Density." International Research Journal Of Ophthalmology 1, no. 1 (2019): 01–12. https://doi.org/10.36811/irjo.2019.110001.

Full text

Abstract:

Idiopathic macular telangiectasia type 2 (IMT2) is a relatively uncommon clinical condition with an estimated prevalence of 1% within the general population. This condition can be challenging to precisely identify in early stages but advancements in clinical imaging to include fluorescein angiography and optical coherence tomography angiography (OCTA) can allow for timely diagnosis and prompt intervention that may leads to improved long-term clinical outcomes. Emerging literature has recognized the role of macular pigment (MP) in IMT2 in terms of Henle fiber layer deposition mechanisms and pot

APA, Harvard, Vancouver, ISO, and other styles

7

HELB, HANS-MARTIN, PETER CHARBEL ISSA, ROB L. P. VAN DER VEEN, TOS T. J. M. BERENDSCHOT, HENDRIK P. N. SCHOLL, and FRANK G. HOLZ. "ABNORMAL MACULAR PIGMENT DISTRIBUTION IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA." Retina 28, no. 6 (2008): 808–16. http://dx.doi.org/10.1097/iae.0b013e31816d81aa.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Engelbert, Michael, and Lawrence A. Yannuzzi. "Idiopathic Macular Telangiectasia Type 2: The Progressive Vasculopathy." European Journal of Ophthalmology 23, no. 1 (2013): 1–6. http://dx.doi.org/10.5301/ejo.5000163.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Sallo, Ferenc B., Irene Leung, Traci E. Clemons, Tunde Peto, Alan C. Bird, and Daniel Pauleikhoff. "MULTIMODAL IMAGING IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA." Retina 35, no. 4 (2015): 742–49. http://dx.doi.org/10.1097/iae.0000000000000365.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Veloso, Carlos E., Raul N. Vianna, David E. Pelayes, and Márcio B. Nehemy. "Intravitreal Bevacizumab for Type 2 Idiopathic Macular Telangiectasia." Ophthalmic Research 49, no. 4 (2013): 205–8. http://dx.doi.org/10.1159/000346130.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Atmani, K., G. Querques, A. Zourdani, N. Benhamou, and E. H. Souied. "Unusual Presentations of Type 2 Idiopathic Macular Telangiectasia." Ophthalmologica 230, no. 3 (2013): 126–30. http://dx.doi.org/10.1159/000354111.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Sallo, Ferenc B., Irene Leung, Mina Chung, et al. "Retinal Crystals in Type 2 Idiopathic Macular Telangiectasia." Ophthalmology 118, no. 12 (2011): 2461–67. http://dx.doi.org/10.1016/j.ophtha.2011.05.022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Narayanan, Raja, Vivek Dave, Padmaja K. Rani, et al. "Multifocal electroretinography in type 2 idiopathic macular telangiectasia." Graefe's Archive for Clinical and Experimental Ophthalmology 251, no. 5 (2012): 1311–18. http://dx.doi.org/10.1007/s00417-012-2191-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Behrens, Alice, Ahmed Sallam, John Pemberton, and Sami Uwaydat. "Tamoxifen Use in a Patient with Idiopathic Macular Telangiectasia Type 2." Case Reports in Ophthalmology 9, no. 1 (2018): 60–66. http://dx.doi.org/10.1159/000485739.

Full text

Abstract:

Crystalline deposits and neurosensory retinal cavitary changes can develop in both tamoxifen retinopathy and nonproliferative idiopathic macular telangiectasia type 2 (MacTel2). MacTel2 is typically differentiated from tamoxifen retinopathy based on the presence of late leakage and mid-phase telangiectatic vessels on fluorescein angiography (FA) and the presence of hyperautofluorescence. Unlike MacTel2, tamoxifen retinopathy is known to be a progressive disease and the cessation of tamoxifen results in resolution of retinopathy. We report a unique case of nonproliferative MacTel2 in a 36-year-

APA, Harvard, Vancouver, ISO, and other styles

15

Aydoğan, Tuğba, Gürkan Erdoğan, Cihan Ünlü, and Ahmet Ergin. "Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia." Türk Oftalmoloji Dergisi 46, no. 6 (2016): 270–73. http://dx.doi.org/10.4274/tjo.23921.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Meyer-ter-Vehn, Tobias, Sina Herzog, Marc Schargus, Winfried Göbel, and Rainer Guthoff. "Long-term course in type 2 idiopathic macular telangiectasia." Graefe's Archive for Clinical and Experimental Ophthalmology 251, no. 11 (2013): 2513–20. http://dx.doi.org/10.1007/s00417-013-2346-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

ZEIMER, MEIKE B., BJÖRN PADGE, BRITTA HEIMES, and DANIEL PAULEIKHOFF. "IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2: DISTRIBUTION OF MACULAR PIGMENT AND FUNCTIONAL INVESTIGATIONS." Retina 30, no. 4 (2010): 586–95. http://dx.doi.org/10.1097/iae.0b013e3181bd2d38.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Niyousha, Mohamad Reza, Narges Hassanpoor, and Sasan Jafari. "Bilateral Type 1 Idiopathic Macular Telangiectasia in a Female Patient: Multimodal Imaging of a Rare Presentation." Case Reports in Ophthalmology 12, no. 2 (2021): 373–79. http://dx.doi.org/10.1159/000513095.

Full text

Abstract:

We report a bilateral case of type 1 idiopathic macular telangiectasia (IMT) in a female patient. A 40-year-old otherwise healthy female with gradual vision loss since 2 years ago with best-corrected visual acuity of 20/400 in both eyes was referred. Her past medical history was negative for any systemic disease including diabetes and systemic hypertension. Color fundus photography showed bilateral loss of normal foveal reflex with macular edema. Fluorescein angiography demonstrated symmetric perifoveal telangiectasia mainly in the superior and nasal macula in both eyes with late staining and

APA, Harvard, Vancouver, ISO, and other styles

19

Issa, Peter Charbel, Hans-Martin Helb, Klaus Rohrschneider, Frank G. Holz, and Hendrik P. N. Scholl. "Microperimetric Assessment of Patients with Type 2 Idiopathic Macular Telangiectasia." Investigative Opthalmology & Visual Science 48, no. 8 (2007): 3788. http://dx.doi.org/10.1167/iovs.06-1272.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Charbel Issa, Peter, Tos T. J. M. Berendschot, Giovanni Staurenghi, Frank G. Holz, and Hendrik P. N. Scholl. "Confocal Blue Reflectance Imaging in Type 2 Idiopathic Macular Telangiectasia." Investigative Opthalmology & Visual Science 49, no. 3 (2008): 1172. http://dx.doi.org/10.1167/iovs.07-0636.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Shukla, D. "Evolution and management of macular hole secondary to type 2 idiopathic macular telangiectasia." Eye 25, no. 4 (2011): 532–33. http://dx.doi.org/10.1038/eye.2010.233.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Miller, Alexander G., Rohit Chandra, Charles Pophal, Jerome P. Schartman, Joan H. Hornik, and David G. Miller. "Efficacy of Macular Hole Surgery in Patients with Idiopathic Macular Telangiectasia Type 2." Ophthalmology Retina 4, no. 5 (2020): 494–97. http://dx.doi.org/10.1016/j.oret.2019.11.017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Shukla, Dhananjay, and Ramesh Venkatesh. "Spontaneous closure of full-thickness macular hole in type 2 idiopathic macular telangiectasia." Graefe's Archive for Clinical and Experimental Ophthalmology 250, no. 11 (2011): 1711–12. http://dx.doi.org/10.1007/s00417-011-1817-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Gedik, Birumut, Muhammet K. Erol, Mehmet Bulut, et al. "Proximal nailfold videocapillaroscopy findings of patients with idiopathic macular telangiectasia type 2." Indian Journal of Ophthalmology 72, Suppl 1 (2023): S148—S152. http://dx.doi.org/10.4103/ijo.ijo_1731_23.

Full text

Abstract:

Purpose: Idiopathic macular telangiectasia type 2 (IMT) is a neurodegenerative disease characterized by bilateral, idiopathic, and perifoveal retinal telangiectatic vessel formations. We aimed to compare proximal nailfold videocapillaroscopy (NV) findings between patients with IMT and healthy individuals and evaluate the optical coherence tomography angiography (OCTA) parameters of the patients with IMT according to their NV findings. Methods: The study included 43 patients with IMT and 92 healthy controls of similar age and gender without any additional diseases. The OCTA and NV findings of t

APA, Harvard, Vancouver, ISO, and other styles

25

Wolf-Schnurrbusch, Ute E. K., Irene Leung, Ferenc B. Sallo, et al. "Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia." Ophthalmic Research 60, no. 1 (2017): 38–42. http://dx.doi.org/10.1159/000479932.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Toy, Brian C., Euna Koo, Catherine Cukras, Catherine B. Meyerle, Emily Y. Chew, and Wai T. Wong. "TREATMENT OF NONNEOVASCULAR IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 WITH INTRAVITREAL RANIBIZUMAB." Retina 32, no. 5 (2012): 996–1006. http://dx.doi.org/10.1097/iae.0b013e31824690a8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Charbel Issa, P., H. P. N. Scholl, A. Gaudric, et al. "Macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia." Eye 23, no. 2 (2008): 435–41. http://dx.doi.org/10.1038/sj.eye.6703003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Vander, J. F. "Macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia." Yearbook of Ophthalmology 2009 (January 2009): 131–32. http://dx.doi.org/10.1016/s0084-392x(09)79101-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Charbel Issa, Peter, Hans-Martin Helb, Frank G. Holz, and Hendrik P. N. Scholl. "Correlation of Macular Function with Retinal Thickness in Nonproliferative Type 2 Idiopathic Macular Telangiectasia." American Journal of Ophthalmology 145, no. 1 (2008): 169–75. http://dx.doi.org/10.1016/j.ajo.2007.08.028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Rijal, Roshija Khanal, Dr Chinmay Nakhwa, and Manavi D. Sindal D. Manavi D Sindal. "Crystalline deposits in the macula – tamoxifen maculopathy or macular telangiectasia?" Nepalese Journal of Ophthalmology 6, no. 2 (2014): 227–29. http://dx.doi.org/10.3126/nepjoph.v6i2.11713.

Full text

Abstract:

Introduction: Tamoxifen citrate is an anti-estrogen agent used in the treatment of breast carcinoma. Crystalline maculopathy is a rare complication of tamoxifen therapy. The clinical picture resembles that of idiopathic macular telangiectasia (IMT) Type 2, which is a more common clinical entity. Objective: To report a case of crystalline maculopathy secondary to tamoxifen and highlight the importance of the medical history and investigations in differentiating it from IMT Type 2. Case: A diabetic female with a past history of breast carcinoma treated with tamoxifen came to the hospital for a r

APA, Harvard, Vancouver, ISO, and other styles

31

Mallias, Ioannis, Panagiota Mylova, and Anastasia Tassiopoulou. "Diagnosis and management of a patient with idiopathic macular telangiectasia type 2." Ophthalmology Journal 2, no. 3 (2017): 83–86. http://dx.doi.org/10.5603/oj.2017.0018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Sallo, Ferenc B., Irene Leung, Wanjiku Mathenge, et al. "The Prevalence of Type 2 Idiopathic Macular Telangiectasia in Two African Populations." Ophthalmic Epidemiology 19, no. 4 (2012): 185–89. http://dx.doi.org/10.3109/09286586.2011.638744.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Wolff, Benjamin, Chrysanthi Basdekidou, Vivien Vasseur, José-Alain Sahel, Alain Gaudric, and Martine Mauget-Faÿsse. "“EN FACE” OPTICAL COHERENCE TOMOGRAPHY IMAGING IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA." Retina 34, no. 10 (2014): 2072–78. http://dx.doi.org/10.1097/iae.0000000000000208.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Gedik, Birumut, Muhammet Kazim Erol, Berna Dogan, Mehmet Bulut, Yigit Caglar Bozdogan, and Rojbin Ekinci. "Examination of inflammation markers in patients with idiopathic macular telangiectasia type 2." Journal of Retina-Vitreous 33, no. 4 (2024): 273. https://doi.org/10.37845/ret.vit.2024.33.44.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Bayón-Porras, R. M., I. Pascual-Camps, C. Plaza-Laguardia, and R. Gallego-Pinazo. "Idiopathic macular telangiectasia type 2: Prevalence and a morphometric and phenotypic study." Archivos de la Sociedad Española de Oftalmología (English Edition) 93, no. 3 (2018): 105–12. http://dx.doi.org/10.1016/j.oftale.2017.08.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Issa, Peter Charbel, Hendrik P. N. Scholl, and Frank G. Holz. "SHORT-TERM EFFECTS OF INTRAVITREAL BEVACIZUMAB IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA." Retinal Cases & Brief Reports 1, no. 2 (2007): 79–81. http://dx.doi.org/10.1097/icb.0b013e31802efef2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Gonzalez, Marco A., Diana Shechtman, Jay M. Haynie, and Leo Semes. "Unveiling Idiopathic Macular Telangiectasia: Clinical Applications of Optical Coherence Tomography Angiography." European Journal of Ophthalmology 27, no. 4 (2017): e129-e133. http://dx.doi.org/10.5301/ejo.5000984.

Full text

Abstract:

Purpose Idiopathic macular telangiectasia type 2 (IMT2) is a bilateral acquired maculopathy, with a spectrum of clinical presentations associated with inner retinal telangiectatic vascular anomalies. Cases often are underdiagnosed or misdiagnosed. Current diagnostic modalities such as spectral-domain optical coherence tomography (SD-OCT) and fluorescein angiography (FA) are valuable to the understanding of the clinicopathology. More recently, optical coherence tomography angiography (OCTA), as an emerging noninvasive technology, has been shown to be particularly useful in the assessment and ma

APA, Harvard, Vancouver, ISO, and other styles

38

Moon, Byung Gil, Yoon Jeon Kim, Young Hee Yoon, and Joo Yong Lee. "Use of intravitreal bevacizumab injections to treat type 1 idiopathic macular telangiectasia." Graefe's Archive for Clinical and Experimental Ophthalmology 250, no. 11 (2011): 1697–99. http://dx.doi.org/10.1007/s00417-011-1798-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Sandhu, S. S., and D. H. Steel. "Comment on macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia." Eye 24, no. 6 (2009): 1119. http://dx.doi.org/10.1038/eye.2009.243.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Balaskas, Konstantinos, Irene Leung, Ferenc B. Sallo, Traci E. Clemons, Alan C. Bird, and Tunde Peto. "ASSOCIATIONS BETWEEN AUTOFLUORESCENCE ABNORMALITIES AND VISUAL ACUITY IN IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2." Retina 34, no. 8 (2014): 1630–36. http://dx.doi.org/10.1097/iae.0000000000000110.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

SALLO, F., I. LEUNG, K. BALASKAS, D. PAULEIKHOFF, AC BIRD, and T. PETO. "Topographic distribution of vascular and neurodegenerative signs in type 2 idiopathic macular telangiectasia." Acta Ophthalmologica 91 (August 2013): 0. http://dx.doi.org/10.1111/j.1755-3768.2013.f055.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Issa, P. C., R. P. Finger, F. G. Holz, and H. P. N. Scholl. "Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia." British Journal of Ophthalmology 92, no. 7 (2008): 941–45. http://dx.doi.org/10.1136/bjo.2007.129627.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Roller, A. Brock, James C. Folk, Narendra M. Patel, et al. "INTRAVITREAL BEVACIZUMAB FOR TREATMENT OF PROLIFERATIVE AND NONPROLIFERATIVE TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA." Retina 31, no. 9 (2011): 1848–55. http://dx.doi.org/10.1097/iae.0b013e31820d3feb.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Meleth, Annal D., Brian C. Toy, Divya Nigam, et al. "PREVALENCE AND PROGRESSION OF PIGMENT CLUMPING ASSOCIATED WITH IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2." Retina 33, no. 4 (2013): 762–70. http://dx.doi.org/10.1097/iae.0b013e3182695bb3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Loutfi, Mohamed, Thomas Papathomas, and Ahmed Kamal. "Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)." Case Reports in Ophthalmological Medicine 2014 (2014): 1–5. http://dx.doi.org/10.1155/2014/231913.

Full text

Abstract:

A 65-year-old female presented with visual disturbance in her right eye lasting for over 2 months. Following investigations, she was diagnosed with MacTel type 1 in the right eye. Visual symptoms were refractory to initial treatment with intravitreal bevacizumab and thereafter intravtireal triamicinolone. The patient was then treated with Ozurdex, following which central macular thickness (CMT) decreased (from 397 μm to 286 μm) and visual acuity deteriorated (from logMAR 0.48 to 0.59). At 14 weeks posttreatment with Ozurdex, a recurrence of cystoid macular oedema (CMO) was observed. Following

APA, Harvard, Vancouver, ISO, and other styles

46

Terauchi, Gaku, Celso Soiti Matsumoto, Kei Shinoda, et al. "Pars Plana Vitrectomy Combined with Focal Endolaser Photocoagulation for Idiopathic Macular Telangiectasia." Case Reports in Medicine 2014 (2014): 1–6. http://dx.doi.org/10.1155/2014/786578.

Full text

Abstract:

Background. To report the outcome of pars plana vitrectomy (PPV) combined with intraoperative endolaser focal photocoagulation (PC) on eyes with idiopathic macular telangiectasis (MacTel) type 1.Methods. This was a retrospective study of two female patients with MacTel type 1 who were resistant to focal photocoagulation, sub-Tenon triamcinolone injection, and/or antiangiogenic drugs. The best-corrected visual acuity (BCVA) was determined, and fluorescein angiography (FA) and spectral domain optical coherence tomography (SD-OCT) were performed before and after surgery for up to 19 months.Result

APA, Harvard, Vancouver, ISO, and other styles

47

Ahn, Jayoung, Joon Hong Sohn, and Mingui Kong. "Optical Coherence Tomography Angiography Features of Idiopathic Macular Telangiectasia Type 2 and Macular Branch Retinal Vein Occlusion." Journal of Retina 5, no. 1 (2020): 44–51. http://dx.doi.org/10.21561/jor.2020.5.1.44.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Zeimer, Meike B., Ferenc B. Sallo, Georg Spital, Britta Heimes, Albrecht Lommatzsch, and Daniel Pauleikhoff. "CORRELATION OF OPTICAL COHERENCE TOMOGRAPHY AND MACULAR PIGMENT OPTICAL DENSITY MEASUREMENTS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA." Retina 36, no. 3 (2016): 535–44. http://dx.doi.org/10.1097/iae.0000000000000752.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Narayanan, R., A. B. Majji, N. Hussain, et al. "Characterization of Idiopathic Macular Telangiectasia Type 2 by Fundus Fluorescein Angiography in Indian Population." European Journal of Ophthalmology 18, no. 4 (2008): 587–90. http://dx.doi.org/10.1177/112067210801800414.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Matt, G., S. Sacu, C. Ahlers, et al. "Thirty-month follow-up after intravitreal bevacizumab in progressive idiopathic macular telangiectasia type 2." Eye 24, no. 10 (2010): 1535–42. http://dx.doi.org/10.1038/eye.2010.113.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!